Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies
MetadataShow full item record
AuthorLópez Moreno, Ana; Acuña Morales, Inmaculada; Torres Sánchez, Alfonso; Ruiz Moreno, Ángel; Cerk, Klara; Rivas Velasco, Ana María; Suárez García, Antonio Francisco; Monteoliva Sánchez, Mercedes; Aguilera Gómez, Margarita
Next-generation probioticsCulturingDietary obesogens exposureObesityEndocrine pathogenesisEndobolome
López-Moreno, A... [et al.]. Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies. Nutrients 2021, 13, 1617. [https://doi.org/10.3390/nu13051617]
SponsorshipOBEMIRISK: Knowledge platform for assessing the risk of Bisphenols on gut microbiota and its role in obesogenic phenotype: looking for biomarkers GP/EFSA/ENCO/380 2018/03/G04; FEDER-Infrastructure IE_2019-198
The combination of diet, lifestyle, and the exposure to food obesogens categorized into "microbiota disrupting chemicals" (MDC) could determine obesogenic-related dysbiosis and modify the microbiota diversity that impacts on individual health-disease balances, inducing altered pathogenesis phenotypes. Specific, complementary, and combined treatments are needed to face these altered microbial patterns and the specific misbalances triggered. In this sense, searching for next-generation beneficial microbes or next-generation probiotics (NGP) by microbiota culturing, and focusing on their demonstrated, extensive scope and well-defined functions could contribute to counteracting and repairing the effects of obesogens. Therefore, this review presents a perspective through compiling information and key strategies for directed searching and culturing of NGP that could be administered for obesity and endocrine-related dysbiosis by (i) observing the differential abundance of specific microbiota taxa in obesity-related patients and analyzing their functional roles, (ii) developing microbiota-directed strategies for culturing these taxa groups, and (iii) applying the successful compiled criteria from recent NGP clinical studies. New isolated or cultivable microorganisms from healthy gut microbiota specifically related to obesogens' neutralization effects might be used as an NGP single strain or in consortia, both presenting functions and the ability to palliate metabolic-related disorders. Identification of holistic approaches for searching and using potential NGP, key aspects, the bias, gaps, and proposals of solutions are also considered in this review.